ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 123976 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 123976; 2) Community: the network communities that were significantly associated with the response to NSC 123976; 3) Molecule: the relationships between components within communities and NSC 123976; 4) MDR: the compounds that were significantly associated with the NSC 123976.

NSC Compound Enrichment Correlation
NSC 687958 Null 0.0219024304994663 0.24427442
NSC 736042 5-chloro-2[(E)-2-(4-nitrophenyl)vinyl]-1H-benzimidazole 0.0219024304994663 0.11661992
NSC 745098 21-[2-(N,N-dimethylamino)ethyl]-oxy-.7.alpha.-methyl-19-norpregna-1,3,5(10),17(20)-tetraen-3-ol citrate salt 0.0219024304994663 0.66628316
NSC 762458 Null 0.0219024304994663 0.10969378
NSC 106995 U 24792 0.0219024304994664 0.29556744
NSC 112535 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-[m-[2-(p-nitro-phenoxy)ethoxy]phenyl]-, monohydrochloride (8CI) 0.0219024304994664 0.17740744
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.024108502230778 0.43090905
NSC 20200 [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride 0.024108502230778 -0.15233372
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.024108502230778 0.18091455
NSC 308847 Amonafide 0.024108502230778 0.21519776
Total:41  Current:17    [First] [Prev] [Next] [Last]